ML17362A083

RIC Invitation Letter External Speaker & Forms - 2018 Piefer

ML17362A083
Person / Time
Site:	SHINE Medical Technologies
Issue date:	01/09/2018
From:	Alexander Adams Research and Test Reactors Licensing Projects Branch
To:	Piefer G SHINE Medical Technologies
Montgomery C, NRR/DLP, 415-3398
Shared Package
ML17362A105 -Pkg.	List: ML17362A083
References
CAC MF1395
Download: ML17362A083 (3)

Text

UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 January 9, 2018 Dr. Gregory Piefer

Chief Executive Officer Shine Medical Technologies 2555 Industrial Drive Monona, WI 53713

SUBJECT:

SHINE MEDICAL TECHNOLOGIES - REGULATORY INFORMATION CONFERENCE 2018 INVITATION LETTER, SPEAKER CONFIRMATION FORM, AND EXTERNAL AGREEMENT FORM (CAC MF1395)

Dear Dr. Piefer:

It is my pleasure to invite you to participate as a speaker at NRC's 30 th Regulatory Information Conference (RIC). The RIC will be held on March 13-15, 2018, at the Bethesda North Marriott Hotel and Conference Center, 5701 Marinelli Road, North Bethesda, MD 20852.

This 3-day annual conference is co-sponsored by the Office of Nuclear Reactor Regulation and the Office of Nuclear Regulatory Research, and brings together more than 3,000 participants from over 30 countries representing interested parties from government, industry, international agencies, other interested stakeholders, and members of the public. The RIC fosters communication about U.S. Nuclear Regulatory Commission (NRC) activities, and offers a valuable forum to share perspectives on technical issues and other matters facing the nuclear

industry.

Your participation as a technical session panelist will bring great value to our session entitled , "Progress Toward a Reliable Domestic Supply of Molybdenum-99 [Mo-99]

," which I will be chairing. The session will be held on Wednesday, March 14, 2018, from 1:30 p.m. to 3:00 p.m.

We would like to give participants an opportunity to learn, "What improvements are underway in construction inspection procedures, operation inspection procedures, guidance, and considerations of the impact of proposed rulemakings, on potential medical isotope facilities?" This session details the progress toward licensing and regulating medical isotope facilities and shares the perspectives of regulators, licensee, the Department of Energy, and other stakeholders. I am anticipating that you can speak about recent SHINE activities addressing the future domestic production of Mo-99.

I hope you are able to accept this invitation. You can find RIC-related news and up-to-date conference information by navigating from the NRC's official public website at http://www.nrc.gov. To confirm your participation, please complete and return the enclosed RIC Speaker Confirmation Form and RIC External Speaker Agreement Form to Ms. Cindy Montgomery, our session coordinator, by January 16, 2018. Please contact Ms. Montgomery or me if you have questions. Ms. Montgomery can be reached on 301-415-3398 or Cindy.Montgomery@nrc.gov. Sincerely,

/RA Linh Tran for/

Alexander Adams, Jr., Chief Research and Test Reactors Licensing Branch Division of Licensing Projects Office of Nuclear Reactor Regulation

Docket No. 50-608

Enclosures:

RIC Speaker Confirmation Form

RIC External Speaker Agreement Form

ML17362A083,Letter; ML17355A548 / ML17355A550 Forms; ML17362A105 -Pkg. *concurred via email NRR-088 OFFICE NRR/DLP/PRLB/PM NRR/DLP/PRLB/BC NRR/DLP/PRLB/PM NAME CMontgomery AAdams (LTran for) CMontgomery DATE 12/27/2017 1/9/2017 1/9/2017